Cargando…
Activating mutations in CSF-1R and additional receptor tyrosine kinases in histiocytic neoplasms
Histiocytoses are clonal hematopoietic disorders frequently driven by mutations in BRAF and MEK1/2 kinases. Currently, however, the developmental origins of histiocytoses in patients are not well understood, and clinically meaningful therapeutic targets outside of BRAF and MEK are undefined. Here we...
Autores principales: | Durham, Benjamin H., Rodrigo, Estibaliz Lopez, Picarsic, Jennifer, Abramson, David, Rotemberg, Veronica, De Munck, Steven, Pannecoucke, Erwin, Lu, Sydney X., Pastore, Alessandro, Yoshimi, Akihide, Mandelker, Diana, Ceyhan-Birsoy, Ozge, Ulaner, Gary A., Walsh, Michael, Yabe, Mariko, Petrova-Drus, Kseniya, Arcila, Maria E., Ladanyi, Marc, Solit, David B., Berger, Michael F., Hyman, David M., Lacouture, Mario E., Erickson, Caroline, Saganty, Ruth, Ki, Michelle, Dunkel, Ira J., López, Vicente Santa-María, Mora, Jaume, Haroche, Julien, Emile, Jean-Francois, Decaux, Olivier, Geissmann, Frederic, Savvides, Savvas N., Drilon, Alexander, Diamond, Eli L., Abdel-Wahab, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898787/ https://www.ncbi.nlm.nih.gov/pubmed/31768065 http://dx.doi.org/10.1038/s41591-019-0653-6 |
Ejemplares similares
-
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
por: Diamond, Eli L., et al.
Publicado: (2023) -
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only Sequencing
por: Ceyhan-Birsoy, PhD, Ozge, et al.
Publicado: (2020) -
Efficacy of MEK Inhibition in Patients with Histiocytic Neoplasms
por: Diamond, Eli L., et al.
Publicado: (2019) -
Engineering and crystal structure of a monomeric FLT3 ligand variant
por: Pannecoucke, Erwin, et al.
Publicado: (2021) -
Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome
por: Breen, Kelsey E., et al.
Publicado: (2020)